Windsor Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Windsor Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,663	Closed	-$93K	–	399
2015 Q3	$93K	Buy	+1,663	New	+$108K	0.05%	129
2014 Q1	–	Sell	-2,304	Closed	-$92K	–	274
2013 Q4	$92K	Buy	2,304 +7	+0.3%	+$276	0.05%	124
2013 Q3	$87K	Buy	2,297 +8	+0.3%	+$312	0.05%	129
2013 Q2	$90K	Buy	+2,289	New	+$89.1K	0.05%	113

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Windsor Capital Management's TEVA Position: Q4 2015 in Review

Windsor Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2015, closing a stake of 1,663 shares — an estimated $93K sold.

Windsor Capital Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $93K in Q3 2015. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Windsor Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2015 after selling out during the quarter.
Windsor Capital Management sold 1,663 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $93K.
Windsor Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 4 quarters.
Windsor Capital Management's Teva Pharmaceutical Industries Limited position peaked at $93K in Q3 2015.
877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on Windsor Capital Management's 13F filing for Q4 2015, filed 1 Feb 2016.